Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601485-22-000012
Filing Date
2022-03-04
Accepted
2022-03-04 16:21:14
Documents
1
Period of Report
2022-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164642885246988.html 4  
1 FORM 4 wf-form4_164642885246988.xml 4 6377
  Complete submission text file 0001601485-22-000012.txt   7767
Mailing Address C/O ADAMAS PHARMACEUTICALS INC. 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address
Rhodes Jennifer J (Reporting) CIK: 0001568249 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 22714336

Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Issuer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations